Global metabolomic profiling of acute myocarditis caused by Trypanosoma cruzi infection.
Ontology highlight
ABSTRACT: Chagas disease is caused by Trypanosoma cruzi infection, being cardiomyopathy the more frequent manifestation. New chemotherapeutic drugs are needed but there are no good biomarkers for monitoring treatment efficacy. There is growing evidence linking immune response and metabolism in inflammatory processes and specifically in Chagas disease. Thus, some metabolites are able to enhance and/or inhibit the immune response. Metabolite levels found in the host during an ongoing infection could provide valuable information on the pathogenesis and/or identify deregulated metabolic pathway that can be potential candidates for treatment and being potential specific biomarkers of the disease. To gain more insight into those aspects in Chagas disease, we performed an unprecedented metabolomic analysis
SUBMITTER: Girones N
PROVIDER: S-EPMC4239010 | biostudies-literature | 2014 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA